You are here

Ribavirin

Gilead Drug Combination Cures Hepatitis C in HIV Patients

Yahoo/Bloomberg

Mon, 07/21/14 - 09:13 am

Gilead Sciences

AbbVie to Present Late-Breaking Results from TURQUOISE-II Study in Chronic Hepatitis C Patients with Cirrhosis at the 2014 International Liver Congress

Yahoo/PR NewsWire

Sat, 04/12/14 - 10:15 am

Don't Crown the Hepatitis C Drug Winner Just Yet

Motley Fool

Tue, 11/19/13 - 07:35 am

Gilead Sciences

Pharmasset Takes Lead in Race to Develop Hep C Therapy By Pill

TheStreet.com

Tue, 11/1/11 - 09:01 am

Abbott Laboratories

Bristol-Myers Squibb

BMS-790052 Plus Peginterferon Alfa and Ribavirin Demonstrated up to 83% Sustained Virologic Response 24 Weeks Post-Treatment (SVR24) in Phase II Study of Genotype 1 Hepatitis C Patients

Yahoo/BusinessWire

Sun, 09/18/11 - 12:14 pm

Bristol-Myers Squibb

Peginterferon Alfa